WallStreetZenWallStreetZen

NASDAQ: RLMD
Relmada Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Relmada Therapeutics revenue was $0.00 for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2025) ending on Sep 30, 2025 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, RLMD annual revenue was $0.0, with N/A growth year-over-year.

RLMD revenue history

Current Revenue
$0.0
Current Earnings
-$56.2M
Current Profit Margin
0%

Be the first to know when RLMD announces revenue.

RLMD Revenue History By Year

RLMD Yearly RevenueRLMD RevenueRLMD ChangeRLMD Revenue Growth
2024-12-31$0.00N/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A
2019-12-31$0.00N/AN/A
2018-06-30$0.00N/AN/A
2017-06-30$0.00N/AN/A
2016-06-30$0.00N/AN/A
2015-06-30$0.00N/AN/A

1 of 1

Relmada Therapeutics Revenue FAQ

What was RLMD's revenue last quarter?

On Invalid Date, Relmada Therapeutics (NASDAQ: RLMD) reported Q3 2025 revenue of $0.00 up N/A year over year. In the same quarter last year, Relmada Therapeutics's revenue was $0.00.

What was Relmada Therapeutics's revenue in 2024?

Relmada Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.

How much does Relmada Therapeutics make in a day?

Based on Relmada Therapeutics annual revenue for the past five years, RLMD makes an average of $0.00 per day.

What was Relmada Therapeutics's annual revenue growth in the past year?

As of Q4 2025, Relmada Therapeutics's revenue has grown null year over year. Relmada Therapeutics's revenue in the past year totaled $0.00.

How much does Relmada Therapeutics make in a year?

Relmada Therapeutics's revenue by year for the past five years is:
  • Relmada Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
  • Relmada Therapeutics's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
  • Relmada Therapeutics's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
  • Relmada Therapeutics's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
  • Relmada Therapeutics's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.